BWM
BMY.RT

Baystate Wealth Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Baystate Wealth Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50
Closed – – 868
2020
Q4 		$0 Sell
50
-100
-67% -$213 ﹤0.01% 797
2020
Q3 		$0 Sell
150
-18
-11% -$51 ﹤0.01% 774
2020
Q2 		$1K Buy
+168
New +$606 ﹤0.01% 641

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Baystate Wealth Management's BMY.RT Position: Q1 2021 in Review

Baystate Wealth Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 50 shares.

Baystate Wealth Management first reported a position in BMY.RT in Q2 2020 and held it in 3 quarters. The position peaked at $1K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Baystate Wealth Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Baystate Wealth Management sold 50 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
  • Baystate Wealth Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020 and held it in 3 quarters.
  • Baystate Wealth Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $1K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Baystate Wealth Management's 13F filing for Q1 2021, filed 21 Apr 2021.